Calix[n]arene‐Based Glycoclusters: Bioactivity of Thiourea‐Linked Galactose/Lactose Moieties as Inhibitors of Binding of Medically Relevant Lectins to a Glycoprotein and Cell‐Surface Glycoconjugates and Selectivity among Human Adhesion/Growth‐Regulatory Galectins
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Growing insights into the functionality of lectin–carbohydrate interactions are identifying attractive new targets for drug design. As glycan recognition is regulated by the structure of the sugar epitope and also by topological aspects of its presentation, a suitable arrangement of ligands in synthetic glycoclusters has the potential to enhance their avidity and selectivity. If adequately realized, such compounds might find medical applications. This is why we focused on lectins of clinical interest, acting either as a potent biohazard (a toxin from Viscum album L. akin to ricin) or as a factor in tumor progression (human galectins‐1, ‐3, and ‐4). Using a set of 14 calix[n]arenes (n=4, 6, and 8) with thiourea‐linked galactose or lactose moieties, we first ascertained the lectin‐binding properties of the derivatized sugar head groups conjugated to the synthetic macrocycles. Despite their high degree of flexibility, the calix[6,8]arenes proved especially effective for the plant AB‐toxin, in the solid‐phase model system with a single glycoprotein (asialofetuin) and with human tumor cells in vitro. The bioactivity of the calix[n]arenes was also proven for human galectins. Notably, selectivity for the tested tandem‐repeat‐type galectin‐4 among the three subgroups was determined at the level of solid‐phase and cell assays, the large flexible macrocycles again figuring prominently as inhibitors. Alternate and cone versions of calix[4]arene with lactose units distinguished between galectins‐1 and ‐4 versus galectin‐3 in cell assays. The results thus revealed bioactivity of galactose‐/lactose‐presenting calix[n]arenes for medically relevant lectins and selectivity within the family of adhesion/growth‐regulatory human galectins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eukaryotic glycosylation: whim of nature or multipurpose tool?
Reuter, G., & Gabius, H.-J. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050298 · Cited by 233
Self-citation
Cited by
Biological applications of functionalized calixarenes
Nimse, S. B., & Kim, T. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35233h · Cited by 435
Design and Creativity in Synthesis of Multivalent Neoglycoconjugates
Chabre, Y. M., & Roy, R. (2010) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(10)63006-5 · Cited by 319
Targeting galectin-driven regulatory circuits in cancer and fibrosis
Mariño, K. V., Cagnoni, A. J., Croci, D. O., & Rabinovich, G. A. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00636-2 · Cited by 246
Calixarenes: from biomimetic receptors to multivalent ligands for biomolecular recognition
Sansone, F., Baldini, L., Casnati, A., & Ungaro, R. (2010) · New Journal of Chemistry · doi:10.1039/c0nj00285b · Cited by 167
Self-citationRoy, R., Murphy, P., & Gabius, H.-J. (2016) · Molecules · doi:10.3390/molecules21050629 · Cited by 76
“When combining the oligovalent display with a bioinspired substitution at the 31-position, affinity to galectins-3 and -4 was further enhanced, increasing selectivity against galectin-1 [116,117].”
BackgroundSelf-citation
Metadata
- Authors
- André, S., Sansone, F., Kaltner, H., Casnati, A., Kopitz, J., Gabius, H., & Ungaro, R.
- Venue
- ChemBioChem
- Publisher
- Wiley
- Published
- 2008-06-23
- Volume
- 9
- Issue
- 10
- Pages
- 1649-1661
- ISSN
- 1439-4227 (ISSN-L)
- 1439-7633
- OpenAlex
- W1996541394
- Cited by
- 143
- References
- 1
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.